Therapy News and Research

RSS

Physio-Control announces commercial availability of ReadyLink 12-Lead ECG device

Physio-Control, Inc., a global leader in emergency medical solutions and wholly‐owned subsidiary of Medtronic, Inc.,, today announced commercial availability of the ReadyLink™ 12-Lead ECG device, a new, U.S. Food and Drug Administration (FDA) 510(k)-cleared solution designed to improve care for heart attack patients and expand regional STEMI systems.

From Medtronic 24 Aug 2011

Sarcoma Oncology Center, Aethlon Medical to study ex vivo effectiveness of Hemopurifier

Aethlon Medical, Inc., the pioneer in developing therapeutic filtration devices to address infectious disease and cancer, announced today that it has entered into an agreement with the Sarcoma Oncology Center to study the ex vivo effectiveness of the Aethlon Hemopurifier to remove immunosuppressive exosomes from the blood of advanced-stage cancer patients.

24 Aug 2011

Square 1 Bank extends $6M credit facility to oxygen therapy innovator, Inogen

Square 1 Bank, the exclusive banking partner to entrepreneurs and the venture capital community, proudly announces the extension of a $6 million credit facility to oxygen therapy innovator, Inogen, Inc.

24 Aug 2011

United Therapeutics completes treprostinil diethanolamine Phase 3 trial in PAH

United Therapeutics Corporation announced today the completion of its FREEDOM-C(2) Phase 3 trial of treprostinil diethanolamine, an investigational sustained release oral formulation of treprostinil, a stable synthetic form of prostacyclin, in patients with pulmonary arterial hypertension.

24 Aug 2011

Creighton University receives NIH grant to address diabetes in adult American Indians

Creighton University School of Nursing has received a $207,000, two-year grant from the National Institutes of Health to address the growing problem of type 2 diabetes mellitus in adult American Indians.

24 Aug 2011

First international conference on developmental, translational and clinical pharmacogenomics

The first international conference hosted by the University of South Florida College of Pharmacy will focus on ways to improve health care by customizing drug prescribing and treatment based on an individual's genetic makeup.

24 Aug 2011

Clay modelling could help disturbed teenagers deal with mental health problems

Researchers at The University of Nottingham are to investigate whether the therapeutic effects of clay modelling could help disturbed teenagers deal with their feelings of anger, anxiety and depression.

24 Aug 2011

Smokers more likely to report problems with persistent musculoskeletal pain

Smokers are much more likely to report problems with persistent musculoskeletal pain than non-smokers, according to a new study reported in the Journal of Pain, published by the American Pain Society.

24 Aug 2011

Palliative, hospice care can lessen the suffering cancer brings to patients and families

Being diagnosed with cancer can be devastating, and the treatment can take its toll in physical, emotional, social, and even spiritual ways. Palliative care providers can lessen the suffering cancer brings to patients and their families—both during treatment and at the end of life. Many people don't realize that palliative care to treat symptoms and improve a patient's quality of life can and should be given throughout their illness, not just at the end of life.

24 Aug 2011

Largest ever molecular-genetic study of ependymomas of the cerebellum

Ependymomas are the second most frequent type of malignant brain tumor in children. Ependymoma develops from precursor cells of the tissue that lines the hollow cavities of the brain. Therapy results of ependymoma vary immensely: While in some patients tumor growth comes to a standstill after surgery and radiotherapy, in other children the disease rapidly takes a severe course.

24 Aug 2011

Only 20.6% of Medicaid-covered Ohio youths complete full six month antidepressant treatment

About half of Medicaid-covered children and adolescents in Ohio who are in treatment for depression complete their first three months of prescribed antidepressants, and only one-fifth complete the recommended minimum six-month course of drugs to treat depression, new research suggests.

24 Aug 2011

Craniofacial surgeons employ bipolar electrocautery to temporarily reshape the brain

Plastic surgeons say they have developed a new surgical technique for complex skull reconstruction that could improve functional and aesthetic outcomes in cases that have previously been deemed impossible or unsafe and left patients with unsightly skull deformities requiring them to wear a helmet.

24 Aug 2011

First North American clinical trial to test adult MSC transplantation as a new MS therapy

A team of researchers at three landmark Cleveland institutions have come together to launch a new clinical trial of an experimental treatment for multiple sclerosis.

24 Aug 2011

Celldex announces key in vivo efficacy results of CDX-1135 in Dense Deposit Disease

Celldex Therapeutics, Inc. today announced key in vivo efficacy data for its CDX-1135 program from a collaboration with Drs. Richard Smith and Carla Nester at the University of Iowa.

24 Aug 2011

USPTO issues Notice of Allowance for Spinal Restoration's Biostat System

Spinal Restoration, Inc. announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for claims concerning the delivery device and method of use of the Biostat System for the treatment of discogenic low back pain.

24 Aug 2011

Obesity a brain condition, not just a lifestyle disorder, research confirms

New Australian research has confirmed that obese individuals often perform poorly in reasoning and planning tasks and, likewise, those with poor cognitive function are more vulnerable to excessive weight gain.

23 Aug 2011

BioLineRx second quarter net loss decreases to NIS 16.4 million

BioLineRx Ltd., a biopharmaceutical development company, today reported its results for the second quarter ending June 30, 2011.

23 Aug 2011

MicroRNA biomarkers provide guidance to develop specific gene therapies for glioblastoma

Patients suffering from an aggressive brain cancer will benefit from the results of a University of Illinois study that could advance the development of targeted gene therapies and improve prognosis.

23 Aug 2011

Medtronic first quarter global revenue increases 7% to $4.049 billion

Medtronic, Inc. today announced financial results for its first quarter of fiscal year 2012, which ended July 29, 2011.

From Medtronic 23 Aug 2011

Kerr, Family Health Network partner to reduce medication non-adherence

Family Health Network is pleased to announce its participation in a program in partnership with Kerr Health, a subsidiary of the renowned regional pharmacy chain, Kerr Drug. Kerr Health will deploy Family Health Network's Connected for Life(SM) platform to an initial group of patients who require frequent interaction with a pharmacist to assist them with medication therapy management.

23 Aug 2011

Therapy News and Research

Physio-Control announces commercial availability of ReadyLink 12-Lead ECG device

Sarcoma Oncology Center, Aethlon Medical to study ex vivo effectiveness of Hemopurifier

Square 1 Bank extends $6M credit facility to oxygen therapy innovator, Inogen

United Therapeutics completes treprostinil diethanolamine Phase 3 trial in PAH

Creighton University receives NIH grant to address diabetes in adult American Indians

First international conference on developmental, translational and clinical pharmacogenomics

Clay modelling could help disturbed teenagers deal with mental health problems

Smokers more likely to report problems with persistent musculoskeletal pain

Palliative, hospice care can lessen the suffering cancer brings to patients and families

Largest ever molecular-genetic study of ependymomas of the cerebellum

Only 20.6% of Medicaid-covered Ohio youths complete full six month antidepressant treatment

Craniofacial surgeons employ bipolar electrocautery to temporarily reshape the brain

First North American clinical trial to test adult MSC transplantation as a new MS therapy

Celldex announces key in vivo efficacy results of CDX-1135 in Dense Deposit Disease

USPTO issues Notice of Allowance for Spinal Restoration's Biostat System

Obesity a brain condition, not just a lifestyle disorder, research confirms

BioLineRx second quarter net loss decreases to NIS 16.4 million

MicroRNA biomarkers provide guidance to develop specific gene therapies for glioblastoma

Medtronic first quarter global revenue increases 7% to $4.049 billion

Kerr, Family Health Network partner to reduce medication non-adherence

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News